The Assessment of Volume Status with Body CompositionMonitor in Cancer Patients

Abstract

Objectives: Intravenous (IV) fluid therapy is often needed in patients with the malignant disease during IV chemotherapy. The aim of our study is to evaluate the volume status of cancer patients treated with IV chemotherapy andstandard fluid therapy by using body composition monitor (BCM) measurements. Methods: Thirty chemotherapy cycles of the 30 cancer patients were evaluated. Patients had solid tumors (10.7%) andlymphoproliferative disease (89.3%). Biochemical and hematological parameters and fluid status by using BCM weremeasured on the 1st and fifth days of chemotherapy cycles. Results: Hypovolemia or hypervolemia were found both at baseline and 5. day during IV fluid and chemotherapy incancer patients (1.057±1.68 and 0.78±1.63 p>0.05 respectively). Also according to baseline, serum levels of Na, K, Ca,and body weight were decreased (p